Regression of Pulmonary Lymphangioleiomyomatosis (PLAM)-associated Retroperitoneal Angiomyolipoma Post–Lung Transplantation With Rapamycin Treatment
- 30 April 2008
- journal article
- case report
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 27 (4), 462-465
- https://doi.org/10.1016/j.healun.2008.01.005
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Everolimus in Pulmonary Transplantation: Pharmacokinetics and Exposure–Response RelationshipsThe Journal of Heart and Lung Transplantation, 2006
- Everolimus Versus Azathioprine in Maintenance Lung Transplant Recipients: An International, Randomized, Double-Blind Clinical TrialAmerican Journal of Transplantation, 2006
- Evolution of Proteinuria After Conversion From Calcineurin Inhibitors (CNI) to Sirolimus (SRL) in Renal Transplant Patients: A Multicenter StudyTransplantation Proceedings, 2005
- Registry of the International Society for Heart and Lung Transplantation: Twenty-second Official Adult Lung and Heart-Lung Transplant Report—2005The Journal of Heart and Lung Transplantation, 2005
- Is Sirolimus Responsible for Proteinuria?Transplantation Proceedings, 2005
- Effects of Rapamycin in the Eker Rat Model of Tuberous Sclerosis ComplexPediatric Research, 2005
- Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 PhosphorylationJournal of Biological Chemistry, 2002
- Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairmentThe Journal of Heart and Lung Transplantation, 2002
- Lung Transplantation for Cystic Lung Diseases: Lymphangioleiomyomatosis, Histiocytosis X, and SarcoidosisSeminars in Respiratory and Critical Care Medicine, 2001
- Evidence That Lymphangiomyomatosis Is Caused by TSC2 Mutations: Chromosome 16p13 Loss of Heterozygosity in Angiomyolipomas and Lymph Nodes from Women with LymphangiomyomatosisAmerican Journal of Human Genetics, 1998